The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal Incontinence

NCT06166615 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

148

Enrollment

OTHER

Sponsor class

Conditions

Fecal Incontinence

Interventions

DRUG: Ramosetron
DRUG: Psyllium

Sponsor

Seoul National University Hospital